ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic
Related Posts
Thorp M, Balakasi K, van Oosterhout JJ, Ramesh M, Robson I, Choko A, Shoptaw S, Hoffman R, Cornell M, Dovel K. High-Risk Mobility and Interruption[...]
Evering TH, Saha PT, Moser C, Jilg N, Bender Ignacio RA, Jagannathan P, Corado K, Wongsodirdjo K, Ritz J, Li JZ, Smith DM, Currier JS,[...]
Pérez-Nadales E, Ruiz-Arabi E, Riccucci D, Carratalà J, Paul M, Fernández-Ruiz M, Álvarez-Marín R, Carmona I, de Lucas EM, Rodríguez-Álvarez RJ, David MD, Steinke SM,[...]